DigiPwn
Cyberdramon (X Antibody) (Limited Foil) (Chain of Liberation #EX8-052 U)

Cyberdramon (X Antibody) (Limited Foil) #EX8-052 U

Chain of Liberation · Ultimate · Digimon · Uncommon · 9000 DP · Foil only

Market prices

$7.42 market -3.4% 7d · updated Sep 11

PrintingLowMarketMedian
Foil$5.35$7.42$7.90

Price history

-$5.03 (-40.4%) over 35 days · High $12.45 · Low $7.42

Cyberdramon (X Antibody) (Limited Foil) market price, Feb 22 to Sep 13$12.45$9.93$7.42Feb 22Apr 28Sep 13
Daily prices (35 days)
DayMarketLowMedian
2026-09-13$7.42$5.35$7.90
2026-09-10$7.42$5.35$7.90
2026-09-07$7.68$5.35$7.90
2026-09-04$7.68$5.35$7.90
2026-06-17$9.02$6.00-
2026-06-14$9.23$6.00-
2026-06-10$9.34$6.00-
2026-06-06$9.34$6.00-
2026-06-03$9.54$6.00-
2026-05-29$10.35$6.00-
2026-05-25$10.46$6.00-
2026-05-22$10.55$6.00-
2026-05-18$10.55$6.00-
2026-05-14$10.55$7.50-
2026-05-10$10.72$7.50-
2026-05-07$11.38$7.50-
2026-05-02$11.67$7.50-
2026-04-28$11.67$7.50-
2026-04-25$11.63$7.50-
2026-04-20$11.63$7.50-
2026-04-16$11.76$7.50-
2026-04-13$11.76$7.50-
2026-04-08$11.76$7.50-
2026-04-05$11.81$7.50-
2026-04-01$11.81$7.50-
2026-03-28$12.11$7.50-
2026-03-25$12.11$7.50-
2026-03-21$12.30$7.50-
2026-03-17$12.30$7.50-
2026-03-13$12.30$7.50-
2026-03-08$12.38$9.18-
2026-03-05$12.38$9.18-
2026-03-02$12.45$9.18-
2026-02-25$12.45$9.18-
2026-02-22$12.45$9.18-

Details

Card type
Digimon
Colour
Black
Form
Ultimate
Level
5
Play cost
9
DP
9000
Attribute
Vaccine
Type
Cyborg, X Antibody
Digivolve
Lv.4 Black for 3
Effect
[[Digivolve] [Cyberdramon]: Cost 0] [When Digivolving] If [Cyberdramon]/[X Antibody] is in this Digimon's digivolution cards, you may place 1 Option card with the [Device] trait from your hand or trash in the battle area. [When Digivolving] By trashing 1 of your Option cards in the battle area, [De-Digivolve 2] 1 of your opponent's Digimon.
Inherited effect
[When Attacking] [Once Per Turn] By trashing 1 of your Option cards in the battle area, trash your opponent's top security card.
Set
Chain of Liberation, released 2025-01-10
Card ID
705739

Comments

Sign in to join the conversation.

Loading comments…